Scaffold hopping strategy toward original pyrazolines as selective CB2 receptor ligands

European Journal of Medicinal Chemistry
2012.0

Abstract

In line of a scaffold hopping strategy of pyrazole structures, especially known as potent CB(2) receptor antagonists, we exploited an original and convergent synthesis of a new class of C4-benzyl pyrazolines and derivatives from readily available hydrazones and enones (two or three steps). Making use of a mixture of resin supported reagents strategy an efficient domino process allowed the easy construction of various dihydropyrazoles in 63-83% yields. The obtained family of pyrazolines featured significant hCB(2)/hCB(1) selectivity in favor of hCB(2) receptors while more than 1000-3000 nM affinity was only measured for hCB(1) receptors. This is closely related to pyrazole SR144528 inverse agonist/antagonist, although a partial agonist behavior in the [(35)S]-GTPγS binding assay was mainly measured in our case pointing out a functional switch in action. Furthermore, this hCB(2) selectivity is unique within the pyrazoline CB ligands although the affinity ranging from 251 to 689 nM remains to be improved which give, however, an opportunity for further structure-activity relationship.

Knowledge Graph

Similar Paper

Scaffold hopping strategy toward original pyrazolines as selective CB2 receptor ligands
European Journal of Medicinal Chemistry 2012.0
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: A versatile architecture for CB2 selective ligands
European Journal of Medicinal Chemistry 2014.0
Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties
European Journal of Medicinal Chemistry 2016.0
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
European Journal of Medicinal Chemistry 2017.0
Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands
European Journal of Medicinal Chemistry 2014.0
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1- f ][1,6]naphthyridines as CB 2 receptor antagonists/inverse agonists
Bioorganic & Medicinal Chemistry 2016.0
Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists
Bioorganic & Medicinal Chemistry Letters 2010.0
Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping
European Journal of Medicinal Chemistry 2018.0
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB 2 receptor antagonists
European Journal of Medicinal Chemistry 2015.0
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB<sub>2</sub> Cannabinoid Receptor Partial Agonists
Journal of Medicinal Chemistry 2013.0